Afuco™ Anti-CMV ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-162) (CAT#: AFC-TAB-162)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CMV. It is a human monoclonal antibody for the treatment of infections with cytomegalovirus in patients with AIDS.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Human
- Type
- ADCC enhanced antibody
- Specificity
- Tested positive against native CMV antigen.
- Species Reactivity
- Cytomegalovirus
- Applications
- IF, IP, Neut, FuncS, ELISA, FC
- Conjugate
- Unconjugated
- Generic Name
- Sevirumab
- Related Disease
- Cytomegalovirus (CMV) infections
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- 55 kDa immediate-early protein 1; 45 kDa immediate-early protein 2; CMV; Envelope glycoprotein B; gB; Glycoprotein B; HHV 5; HHV5; Human herpesvirus 5; IE1; IE2; UL122; UL122 regulatory protein IE2; UL123;
Related Resources
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Sevirumab"
Anti-CMV Recombinant Antibody (Sevirumab)Recombinant monoclonal antibody to CMV. Sevirumab (MSL-109) is a human monoclonal antibody for the treatment of infections with cytomegalovirus in patients with AIDS.
DrugMonitor™ Anti-Sevirumab Antibody (VS-1224-YC1080)Sevirumab (MSL-109) is a human monoclonal antibody for treating cytomegalovirus infections in AIDS patients. The DrugMonitor™ Anti-Sevirumab Antibody (VS-1224-YC1080) is an anti-drug antibody (ADA) against Sevirumab. This drug-based antibody is raised in mice immunized with the Sevirumab. The anti-Sevirumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Sevirumab in samples.
See other products for "CMV"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-2-sdAb | Recombinant Anti-CMV VHH Single Domain Antibody | IHC, IP, FC, Neut, FUNC | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-162. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, ELISA, IP, FC, FuncS, Neut, IF
Application: ELISA, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: ELISA
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, FC, IHC, Neut
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.